This study focuses on kidney tumors in younger patients. It aims to collect and store samples of tumor tissue, blood, and urine to study in the lab. By examining these samples, doctors hope to understand more about changes in DNA (deoxyribonucleic acid) and find biomarkers, which are clues about cancer.
Key Points:
- The study lasts for 5 years, with regular check-ups.
- Patients must allow the collection of tissue and blood samples and may undergo tests like CT scans or MRIs.
- Participants need to sign a consent form, with the involvement of their parents or guardians if under 18.
The study is open to those with a first occurrence of any kidney tumor identified by imaging (like CT or MRI). Eligible tumors include Wilms tumor, clear cell sarcoma, and others. Participants must submit various samples and reports for analysis. This study helps scientists understand kidney tumors better and may lead to future treatments. All requirements for human studies by the FDA (Food and Drug Administration) and NCI (National Cancer Institute) must be met, ensuring safety and ethics are maintained.